Results 251 to 260 of about 9,003,952 (365)

Neuropeptide Y in cancer-biological functions and potential clinical implications. [PDF]

Cancer Metastasis Rev
Sigorski D, Sejda A, Abualsaud N, Krawczyk E, Izycka-Swieszewska E, Kitlinska J.   +5 more
europepmc   +1 more source

Real‐world effectiveness and safety of galcanezumab for the treatment of migraine: A systematic review and meta‐analysis

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to summarize and pool real‐world evidence on the clinical effectiveness and safety of galcanezumab. Background Migraine is a disabling primary headache disorder. Several drugs that target calcitonin gene‐related peptide, such as galcanezumab, have recently been developed.
Jaime Fernández‐Bravo‐Rodrigo, Carlos Pascual‐Morena, Alicia Saz‐Lara, Irene Martínez‐García, Carla Geovanna Lever‐Megina, Silvana Patiño‐Cardona, Amparo Flor‐García, Iván Cavero‐Redondo   +7 more
wiley   +1 more source

Associations between serum neuropeptide Y levels and anxiety, depression, and quality of life in Chinese patients with primary glaucoma. [PDF]

BMC Ophthalmol
Cheng K, Quan F, Dai L, Gu C, Yu L.
europepmc   +1 more source

A retrospective audit of the real‐world safety and effectiveness profile of eptinezumab for treatment‐resistant chronic migraine in Australia

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To describe the real‐world safety, tolerability, and effectiveness of eptinezumab for chronic migraine prevention in Australia. Background Eptinezumab is a relatively new medication for treatment‐resistant chronic migraine prevention.
Lakshini Gunasekera, Shuli Cheng, Emma Foster, Shobi Sivathamboo, Terence O'Brien, Helmut Butzkueven, Jayashri Kulkarni, Elspeth Hutton   +7 more
wiley   +1 more source

α-Substituted N-(Sulfonamido)alkyl-β-aminotetralins:  Potent and Selective Neuropeptide Y Y5 Receptor Antagonists

, 2000
Mark A. Youngman, James J. McNally, Timothy W. Lovenberg, Allen B. Reitz, Nicole M. Willard, Diane Nepomuceno, Sandy J. Wilson, Jeffrey J. Crooke, Daniel I. Rosenthal, Anil H. Vaidya, Scott L. Dax   +10 more
openalex   +1 more source

Noradrenaline and neuropeptide Y contribute to initial, but not sustained, vasodilatation in response to local skin warming in humans

Experimental Physiology, 2014
G. Hodges, Paul A Sparks
semanticscholar   +1 more source

Neuropeptide Y neurons mediate opioid-induced itch by disinhibiting GRP-GRPR microcircuits in the spinal cord. [PDF]

Nat Commun
Zeng Q, Li Y, Wu Y, Wu J, Xu K, Chen Y, Rao Y, Li N, Luo Y, Jiang C, Wu C, Wang Z.   +11 more
europepmc   +1 more source

Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene‐related peptide sensitization

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The aim of this study was to determine the photoreceptor basis of light avoidance in mice and assess the effect of CGRP sensitization on this behavior. Background Prior studies have suggested that photophobia is mediated by a subset of retinal ganglion cells (RGCs) that contain melanopsin, making them intrinsically photosensitive ...
Eric A. Kaiser, Audrey Cavanah, Geoffrey K. Aguirre, Frances E. Jensen   +3 more
wiley   +1 more source

The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice.

Proceedings of the National Academy of Sciences of the United States of America, 1998
C. Broberger, J. Johansen, C. Johansson, M. Schalling, Tomas Hökfelt   +4 more
semanticscholar   +1 more source

Neuropeptide Y neurons surrounding the locus coeruleus inhibit noradrenergic system activity to reduce anxiety. [PDF]

Sci Adv
Riga D, Kooij KL, Rademakers K, Wolterink-Donselaar IG, Basak O, Meye FJ.   +5 more
europepmc   +1 more source